NL-OMON41159已完成不适用
A phase 1, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]pacritinib following a single oral dose in healthy male subjects. - PAC102 (CS0218)
CTI BioPharma Corporation0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Non-smoking men between 18 and 55 years of age (inclusive).
排除标准
- •Any severe acute or chronic medical condition, psychiatric condition, or laboratory abnormality that in the Investigator's opinion may increase the risk associated with study participation or administration of study treatment, or interfere with the interpretation of study results (such as gastrointestinal surgical history or obstructive uropathy).
研究者
相似试验
已完成
不适用
A phase I, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]QLT091001 following single oral dose in healthy male subjectsNL-OMON35776QLT Inc.6
已完成
不适用
A phase I, open label study to investigate the absorption, metabolism and excretion of 14C-ESN-364 in healthy menopausal female volunteers.NL-OMON46563Ogeda6
已完成
1 期
A mass-balance study of [14C]KDT-3594 in healthy adult maleHealthy conditionJPRN-jRCT2071220057Shimizu Yoshitaka8
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism and excretion of 14C-JNJ-63623872 after a single dose in healthy male subjectsInfluenza ARNA-virus10047438NL-OMON42724Janssen-Cilag6
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism, and excretion of 14C-JNJ-53718678 after a single oral dose in healthy adult male subjectsRSV10047438NL-OMON43122Janssen Sciences Ireland UC6